Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).
Saved in:
| Title: | Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ). |
|---|---|
| Authors: | Sunhary De Verville, Pierre-Louis (AUTHOR), Stubbs, Brendon (AUTHOR), Etchecopar-Etchart, Damien (AUTHOR), Godin, Ophélia (AUTHOR), Andrieu-Haller, Christelle (AUTHOR), Berna, Fabrice (AUTHOR), Aouizerate, Bruno (AUTHOR), Capdevielle, Delphine (AUTHOR), Chereau, Isabelle (AUTHOR), Clauss-Kobayashi, Julie (AUTHOR), Coulon, Nathalie (AUTHOR), Dorey, Jean-Michel (AUTHOR), Dubertret, Caroline (AUTHOR), Leignier, Sylvain (AUTHOR), Mallet, Jasmina (AUTHOR), Misdrahi, David (AUTHOR), Passerieux, Catherine (AUTHOR), Pignon, Baptiste (AUTHOR), Rey, Romain (AUTHOR), Urbach, Mathieu (AUTHOR) |
| Source: | European Archives of Psychiatry & Clinical Neuroscience. Oct2022, Vol. 272 Issue 7, p1273-1282. 10p. 2 Charts. |
| Subjects: | World Health Organization, Physical activity, Psychological well-being, Schizophrenia, Patient compliance, Mood stabilizers |
| Abstract: | The World Health Organization (WHO) recommends adults complete 150–300 min per week of moderate physical activity or 75–150 min of vigorous physical activity or an equivalent combination of both, to optimize health. To explore the factors associated with adequate MVPA in stabilized outpatients with schizophrenia. 425 stabilized outpatients were recruited in the national FACE-SZ cohort between 2015 and 2018 were evaluated with the International Physical Activity Questionnaire and a 1-day long standardized battery. We explored in multivariate analyses the clinical and pharmacological factors associated with MVPA (model 1) and the biological factors and patient-reported outcomes (model 2). Overall, only 86 (20.2%) of the 425 participants achieved the recommended MVPA threshold. In model 1, the adequate MVPA group was associated with younger age, mood stabilizers prescription and adherence to treatment, independent of sex, positive and depressive symptoms, first-generation antipsychotics prescription, anxiolytic medication, and akathisia. In model 2, adequate MVPA was associated with better glycemic and lipidic profile and better physical and psychological well-being, self-esteem, sentimental life, and resilience independently of age, sex, and current psychotic severity. The expert centers recommend the importance of promoting promote effective MVPA programs for stabilized patients with schizophrenia. Interventions studies suggest that MVPA may be a useful strategy to maximize physical and psychological well-being and self-esteem and potentially to prevent or manage metabolic disturbances. [ABSTRACT FROM AUTHOR] |
| Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The World Health Organization (WHO) recommends adults complete 150–300 min per week of moderate physical activity or 75–150 min of vigorous physical activity or an equivalent combination of both, to optimize health. To explore the factors associated with adequate MVPA in stabilized outpatients with schizophrenia. 425 stabilized outpatients were recruited in the national FACE-SZ cohort between 2015 and 2018 were evaluated with the International Physical Activity Questionnaire and a 1-day long standardized battery. We explored in multivariate analyses the clinical and pharmacological factors associated with MVPA (model 1) and the biological factors and patient-reported outcomes (model 2). Overall, only 86 (20.2%) of the 425 participants achieved the recommended MVPA threshold. In model 1, the adequate MVPA group was associated with younger age, mood stabilizers prescription and adherence to treatment, independent of sex, positive and depressive symptoms, first-generation antipsychotics prescription, anxiolytic medication, and akathisia. In model 2, adequate MVPA was associated with better glycemic and lipidic profile and better physical and psychological well-being, self-esteem, sentimental life, and resilience independently of age, sex, and current psychotic severity. The expert centers recommend the importance of promoting promote effective MVPA programs for stabilized patients with schizophrenia. Interventions studies suggest that MVPA may be a useful strategy to maximize physical and psychological well-being and self-esteem and potentially to prevent or manage metabolic disturbances. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 09401334 |
| DOI: | 10.1007/s00406-022-01384-x |
